Search - tctmd.com

Displaying 441 - 460 of 501

Sort: Relevancy | Date

News Daily News

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

Jason Kahn

March 05, 2012

News Daily News

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

February 21, 2012

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

L.A. McKeown

February 20, 2012

News Daily News

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Yael L. Maxwell

February 15, 2012

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

Presentation

Ensayo Aleatorizado Multicentro Comparador de Amfilimus con Stents Liberadores de Paclitaxel en Lesiones Coronarias Nativas De Novo

Presenter: Didier Carri?

January 24, 2012

Presentation

A Multicenter Randomized Trial Comparing Amphilimus- With Paclitaxel-Eluting Stents in De Novo Native Coronary Artery Lesions

Presenter: Didier Carrie

January 24, 2012

News Daily News

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

Jason Kahn

January 08, 2012

News Daily News

SCAAR: Second-Generation DES Improve Hard Outcomes

Yael L. Maxwell

January 08, 2012

Presentation TCT 2012

Two Years Clinical Outcomes of Diabetic Patients Treated With a New Generation Drug-Eluting Stent.

Presenter: Francesco Saia, William Wijns, Ran Kornowski, Patrick Joly, Fraser Witherow, Enrique Novo Garcia, Dezs? Apr?, Ismail Ates, Ernst G. Vester, Petr Kala, Sinan Dagdelen, Gian Battista Danzi

January 03, 2012

Presentation TCT 2012

New Generation Drug Eluting Stent Nobori: 2 Year Clinical Outcome of Patients with Chronic Total Occlusion.

Presenter: Bernard Chevalier, Dragan Sagic, Carlo Trani, Damras Tresukosol, Peep Laanmets, Mario Lombardi, Enrique Novo Garcia, Stefan Hoffmann, Harald Schwacke, Werner Jung, David Hildick-Smith, Gian Battista Danzi

January 03, 2012

Presentation TCT 2012

First Report of A Novel Polymer-Free Dual-Drug Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man BICARE Trial

Presenter: Mengyue Yu, Bo Xu, Yongjian Wu, Hongbing Yan, Jue Chen, Jie Qian, Chaowei Mu, Fenghuan Hu, Weixian Yang, Shubin Qiao, Yuejin Yang, Run-Lin Gao

January 03, 2012

Presentation TCT 2012

First Report of A Novel Abluminal Groove Filled Biodegradable Polymer Rapamycin-Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man FIREHAWK Trial

Presenter: Bo Xu, Jie Qian, Alexandra J. Lansky, Yuejin Yang, Shubin Qiao, Yongjian Wu, Jue Chen, Fenghuan Hu, Weixian Yang, Gary S. Mintz, Martin B. Leon, Run-Lin Gao

January 03, 2012

News Conference News

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

Yael L. Maxwell

November 30, 2011

News Conference News

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Jason Kahn

November 30, 2011

News Daily News

Some New-Generation Stents Prone to Longitudinal Distortion

November 29, 2011

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Conference News

Advertisement

Angiotensin Blocker Preserves Endothelial Function Better Than Calcium Antagonist

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

Ensayo Aleatorizado Multicentro Comparador de Amfilimus con Stents Liberadores de Paclitaxel en Lesiones Coronarias Nativas De Novo

A Multicenter Randomized Trial Comparing Amphilimus- With Paclitaxel-Eluting Stents in De Novo Native Coronary Artery Lesions

Stent Thrombosis, TLR Persist at Low Levels out to 5 Years with First-Gen DES

SCAAR: Second-Generation DES Improve Hard Outcomes

Two Years Clinical Outcomes of Diabetic Patients Treated With a New Generation Drug-Eluting Stent.

New Generation Drug Eluting Stent Nobori: 2 Year Clinical Outcome of Patients with Chronic Total Occlusion.

First Report of A Novel Polymer-Free Dual-Drug Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man BICARE Trial

First Report of A Novel Abluminal Groove Filled Biodegradable Polymer Rapamycin-Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man FIREHAWK Trial

ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions

COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions

Some New-Generation Stents Prone to Longitudinal Distortion

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content